Cancer-induced Weakness in Immune System May Be Key to HER2+ Breast Cancer …

Cancer-induced Weakness in Immune System May Be Key to HER2+ Breast Cancer …

T cells from patients whose breast cancer had recently recurred showed far weaker response to the HER2 receptor protein, compared with T cells from patients whose breast cancer had not recurred over a long period following treatment, according to a

(Visited 1 times, 1 visits today)
6
Like
Save

Comments

Comments are disabled for this post.